Status:
UNKNOWN
Molecular Diagnosis of Allergic Contact Dermatitis
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
Contact Dermatitis
Contact Dermatitis Irritant
Eligibility:
All Genders
18+ years
Brief Summary
Allergic contact dermatitis (ACD) is a common inflammatory skin disease, affecting approximately 15-20% of the general population in industrialized countries and ranking first among occupational disea...
Eligibility Criteria
Inclusion
- Patient, male or female, over 18 years of age
- Patient with active contact dermatitis lesion biopsied for molecular analysis
- Patients who have undergone patch testing
- Patients whose positive patch tests were biopsied for molecular analysis
- Written informed consent given prior to any study-related procedure
- Between 01/01/2020 and 31/12/2025
Exclusion
- Missing clinical data
- Patient objecting to use of data
Key Trial Info
Start Date :
April 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2026
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT06177314
Start Date
April 1 2023
End Date
January 1 2026
Last Update
December 20 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier Lyon Sud
Pierre-Bénite, France, 69495